Secure payment on i-micronews Contact Yole Développement for I Micronews reports

RSS I-micronewsYole Dévelopement on TwitterYole Développement on Google +LinkedIn Yole pageSlideshare Yole Développement I-Micronews

MedTech

NanoString is a biomedical company that is first to class with their digital molecular barcoding technology. NanoString develops devices that analyze multiple analyte types simultaneously from one sample of tissue. That means that in the same tube a researcher can study a pathway through a multiplexed approach, capturing mRNA, DNA, and protein expression.

Read more ...

2015 is a year of change for the sample preparation market, announce Yole Développement (Yole) analysts in the latest report Sample Preparation Automation through Emerging Microfluidic Technologies Report 2015. End-users’ need is to decrease the number of human manipulation errors within the biological sample preparation process and increase the production flow by reducing the number of steps.

Read more ...

Merck, a leading science and technology company, announced the completion of its $ 17 billion acquisition of Sigma-Aldrich, creating one of the leaders in the $ 130 billion global industry to help solve the toughest problems in life science.

Read more ...

Biocartis, an innovative molecular diagnostics company, announces the launch of its first infectious disease test on the Idylla™ platform. The Idylla™ Respiratory IFV-RSV Panel has been developed by Janssen Diagnostics and is intended for the detection of various strains of Influenza Virus (IFV) and Respiratory Syncytial Virus (RSV). The Idylla™ Respiratory IFV-RSV Panel received CE-IVD marking on 18 November 2015 and is being launched for commercial use in Europe and other geographies recognising the CE-mark. Janssen Diagnostics has appointed Biocartis as co-exclusive worldwide distributor of the test.

Read more ...

Pfizer and Allergan announced that their boards of directors have unanimously approved, and the companies have entered into, a definitive merger agreement under which Pfizer, a global innovative biopharmaceutical company, will combine with Allergan, a global pharmaceutical company and a leader in a new industry model – Growth Pharma, in a stock transaction currently valued at $363.63 per Allergan share, for a total enterprise value of approximately $160 billion, based on the closing price of Pfizer common stock of $32.18 on November 20, 2015.

Read more ...

A team of graduate students from the School of Engineering and Applied Science were among seven finalists at the Collegiate Inventors Competition earlier this week. Cassidy Blundell, Nicholas Perkons, and Jeongyun Seo presented their “eye-on-a-chip” to a team of experts from industry and academia, making the case that their device represents a more reliable, accurate, and ethical alternative to animal testing.

Read more ...

Upcoming Events


> BIOtech Japan 2018
(June 27 - June 29, Tokyo, Japan)

Presentation

Point of Need Testing & Liquid Biopsy Technology and Market Overview:Challenges, market trends and new solutions
Discover the presentation held by Asma Siari at LOAC Europe 2018, on June 5, 2018, in Rotter...
BioMEMS, the next big thing for MEMS players ?
Discover the presentation held by Sébastien Clerc at MEMS & Sensors Executive Congress, in ...
Status of the Microfluidics Industry
Discover the presentation held by Sébastien Clerc at Sensor China Conference of September 1...

Access to all our presentations